Eden Prairie-based Surmodics' stock soared Wednesday following news of its impending sale that will take the medical device company private. Private equity firm GTCR, based in Chicago, will pay $627 million or $43 per share for Surmodics when the transaction closes in the second half of the year, pending shareholder and regulatory approval. Health care and technology make up a main sector of ...